Found: 7
Select item for more details and to access through your institution.
The cytochrome P450 2D6 (CYP2D6) enzyme polymorphism: Screening costs and influence on clinical outcomes in psychiatry<sup>*</sup>.
- Published in:
- Clinical Pharmacology & Therapeutics, 1996, v. 60, n. 5, p. 522, doi. 10.1016/S0009-9236(96)90148-4
- By:
- Publication type:
- Article
How Well Can Centenarians Hear?
- Published in:
- PLoS ONE, 2013, v. 8, n. 6, p. 1, doi. 10.1371/journal.pone.0065565
- By:
- Publication type:
- Article
Population pharmacokinetic-pharmacodynamic analysis of vernakalant hydrochloride injection (RSD1235) in atrial fibrillation or atrial flutter.
- Published in:
- Journal of Pharmacokinetics & Pharmacodynamics, 2011, v. 38, n. 5, p. 541, doi. 10.1007/s10928-011-9207-3
- By:
- Publication type:
- Article
Dose-Response Analysis of the Effect of Carbidopa-Levodopa Extended-Release Capsules (IPX066) in Levodopa-Naive Patients With Parkinson Disease.
- Published in:
- Journal of Clinical Pharmacology, 2016, v. 56, n. 8, p. 974, doi. 10.1002/jcph.683
- By:
- Publication type:
- Article
Population Pharmacodynamics of IPX066: An Oral Extended-Release Capsule Formulation of Carbidopa-Levodopa, and Immediate-Release Carbidopa-Levodopa in Patients With Advanced Parkinson's Disease.
- Published in:
- Journal of Clinical Pharmacology, 2013, v. 53, n. 5, p. 523, doi. 10.1002/jcph.63
- By:
- Publication type:
- Article
Population Pharmacokinetics of Vernakalant Hydrochloride Injection (RSD1235) in Patients With Atrial Fibrillation or Atrial Flutter.
- Published in:
- Journal of Clinical Pharmacology, 2012, v. 52, n. 7, p. 1042, doi. 10.1177/0091270011408425
- By:
- Publication type:
- Article
Pharmacokinetics of Novel Atrial-Selective Antiarrhythmic Agent Vernakalant Hydrochloride Injection (RSD1235): Influence of CYP2D6 Expression and Other Factors.
- Published in:
- Journal of Clinical Pharmacology, 2009, v. 49, n. 1, p. 17, doi. 10.1177/0091270008325148
- By:
- Publication type:
- Article